Bank of New York Mellon’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $142K | Hold |
|
|||||
|
2024
Q4 | $431K | Sell |
|
|||||
|
2024
Q3 | $814K | Sell |
|
|||||
|
2024
Q2 | $851K | Buy |
|
|||||
|
2024
Q1 | $1.26M | Buy |
|
|||||
|
2023
Q4 | $673K | Buy |
|
|||||
|
2023
Q3 | $593K | Sell |
|
|||||
|
2023
Q2 | $789K | Buy |
|
|||||
|
2023
Q1 | $270K | Buy |
|
|||||
|
2022
Q4 | $21.3K | Hold |
|
|||||
|
2022
Q3 | $54K | Sell |
|
|||||
|
2022
Q2 | $105K | Sell |
|
|||||
|
2022
Q1 | $164K | Sell |
|
|||||
|
2021
Q4 | $281K | Buy |
|
|||||
|
2021
Q3 | $469K | Buy |
|
|||||
|
2021
Q2 | $623K | Buy |
|
|||||
|
2021
Q1 | $462K | Buy |
|
|||||
|
2020
Q4 | $440K | Buy |
|
|||||
|
2020
Q3 | $509K | Buy |
|